What's new

Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Questions and answers clinic on post-authorisation procedure management in IRIS,...

Next Article

Human medicines European public assessment report (EPAR): Elucirem, Gadopiclenol...

Related Posts

Summary of opinion: Tremfya, 27/03/2025 Positive

Summary of opinion: Tremfya, 27/03/2025 Positive

Mar 28, 2025  0

Human medicines European public assessment report (EPAR): Samsca, tolvaptan, Date of authorisation: 02/08/2009, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0

Herbal medicinal product: Passiflorae herba, Passiflora incarnata L., F: Assessment finalised

Herbal medicinal product: Passiflorae herba, Passiflora...

Feb 28, 2025  0